Search results for "COPD"


 
Results 21 - 30 of about 120 for "COPD".
Sort by: Relevance | Newest | Oldest

Triple inhaler therapy associated with reduced COPD exacerbations, higher rates of pneumonia

Results of the systematic review and meta-analysis suggest that triple inhaler therapy should be limited to patients with more severe symptoms of chronic obstructive pulmonary disease (COPD) that cannot be adequately managed by dual therapy, the authors said.
https://immattersacp.org/weekly/archives/2018/11/13/2.htm
13 Nov 2018

New drugs approved for hypertension, lupus and COPD

Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/05/fda.htm
1 May 2011

MKSAP Quiz: Routine follow-up for very severe COPD

A 75-year-old man is seen for routine follow-up for very severe COPD. He has constant dyspnea and air hunger and spends most of the day in a chair. He has had no change in baseline cough and sputum production. He has had multiple COPD exacerbations that required ICU admission and intubation. He has not benefited from pulmonary rehabilitation in the past. What is the most appropriate management?
https://immattersacp.org/weekly/archives/2017/11/07/3.htm
7 Nov 2017

New model found to help predict 20-year risk of COPD

Prediction of future lung function could let clinicians identify those at high risk for chronic obstructive pulmonary disease (COPD), but the trajectory of lung function decline varies greatly among individuals, the authors noted.
https://immattersacp.org/weekly/archives/2019/10/01/4.htm
1 Oct 2019

New COPD treatment, warnings on insomnia and migraine drugs

This regulatory update covers approval of a combined long-term maintenance treatment for chronic obstructive pulmonary disease, warnings against driving after taking insomnia drugs and on use of migraine drugs in pregnant women, and more.
https://immattersacp.org/archives/2013/07/fda.htm
1 Jul 2013

MKSAP Quiz: Follow-up for severe COPD

A 55-year-old man is evaluated in follow-up for severe COPD, which was diagnosed 2 years ago. He has had two exacerbations in the past year requiring hospitalization, and his baseline exercise tolerance is low. Following a physical exam and other tests, what is most likely to benefit this patient?
https://immattersacp.org/weekly/archives/2018/08/14/3.htm
14 Aug 2018

New drugs approved for type 2 diabetes and COPD

This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014

Guidance on using rapid tests, managing COPD, and screening for cardiac problems in COVID-19

The FDA warned about false positives with rapid tests, guidance addressed care for chronic obstructive pulmonary disease (COPD) during the pandemic, and experts advised on ethics of emergency use authorizations, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2020/11/10/1.htm
10 Nov 2020

New questionnaire appears to successfully identify COPD in primary care settings

A survey, combined with selective peak expiratory flow, was the best method for predicting undiagnosed, clinically significant chronic obstructive pulmonary disease, a recent case-control study found.
https://immattersacp.org/weekly/archives/2016/11/08/5.htm
8 Nov 2016

A new approach to diverticulitis

Evidence is fueling new guidelines suggesting internists treat most cases of uncomplicated diverticulitis in an outpatient setting, without antibiotics.
https://immattersacp.org/archives/2022/04/a-new-approach-to-diverticulitis.htm
1 Apr 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next